Viewing nowEdaphar Tablet 10mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Ahn-Guk Pharmaceutical Co., Ltd.

MFDS item code 202202177 · Approved 2022.05.23 · Insurance code 650205890
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to dietary and exercise therapy for better blood sugar control in patients with type 2 diabetes and can be given alone or in combination with other medications. It is particularly important to consult an expert if the patient has heart or vascular diseases or risk factors among those with poor blood sugar control. Overall, this medication aids blood sugar management in patients with type 2 diabetes and helps manage the risk of cardiovascular events.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in patients who have had an allergic reaction to the active ingredient or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with lactose intolerance or specific genetic disorders should not take this medication. It is also unsuitable for patients undergoing dialysis. Administration should be cautious in patients with fluid volume deficiency or poor renal function as it may lead to hypotension or renal damage, necessitating careful monitoring. During treatment, there may be an increased risk of genital infections and urinary tract infections, so immediate consultation with healthcare professionals is warranted if any infection symptoms occur. There is a risk of hypoglycemia when taken with insulin or sulfonylureas, so patients should be aware of hypoglycemic symptoms and may need dosage adjustments. Dehydration and hypotension may occur due to reduced fluid volume, so adequate hydration and careful monitoring of symptoms are necessary. Diabetic ketoacidosis may occur rarely, so if symptoms such as vomiting, abdominal pain, or shortness of breath arise, immediate medical attention should be sought. Patients with poor liver function, the elderly, or those taking diuretics should closely monitor their renal function and fluid status. Pregnant or breastfeeding women should avoid this medication, and if pregnancy is confirmed, discontinue use immediately. There is no specific antidote for overdose, so appropriate treatment should be administered based on symptoms, per a doctor’s guidance. This medication does not significantly affect driving or machinery operation, but caution is advised in cases of potential hypoglycemia. The product should be stored out of reach of children and kept in its original container for safety.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance at the start of treatment, dyslipidemia, elevated serum creatinine at the start of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, urosepsis, acute kidney injury, gastroesophageal reflux disease, upper abdominal pain, diverticulitis, bowel perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, sensory loss, headache, nasopharyngitis, upper respiratory tract infection, chest pain, fatigue, edema, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, menstrual irregularities, hair loss, dermatitis, xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating dysregulation eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; it should be stored in a sealed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This helps maintain the medication's effectiveness for a longer time.
Yellow, double-convex, diamond-shaped film-coated tablets
PTP - 28 tablets/box [7 tablets/PTP x 4], Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Ahn-Guk Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.